source
- Bristol Myers Squibb signs up to $15.2 billion partnership with China's Hengrui PharmaBristol Myers Squibb announced a licensing partnership with China's Hengrui Pharma covering more than a dozen early-stage drug programs. The agreement includes a $600 million upfront payment to He…
- Serif Biomedicines claims breakthrough in non-viral gene therapy demonstrated in monkeysSerif Biomedicines, a startup launched by Flagship Pioneering last month, announced it believes it has overcome two key technical hurdles that have limited non-viral gene therapy. The company says…